tradingkey.logo
搜尋

Crinetics Pharmaceuticals Inc

CRNX
添加自選
83.750USD
-0.100-0.12%
收盤 07-27 16:00美東報價延遲15分鐘
8.82B總市值
虧損本益比TTM

Crinetics Pharmaceuticals Inc

83.750
-0.100-0.12%

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
其他
61.10%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
其他
61.10%
股東類型
持股股東
佔比
Investment Advisor
49.95%
Investment Advisor/Hedge Fund
40.84%
Hedge Fund
14.42%
Venture Capital
1.76%
Research Firm
1.71%
Individual Investor
1.57%
Private Equity
0.95%
Bank and Trust
0.58%
Pension Fund
0.40%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
556
115.89M
109.92%
-3.16M
2025Q4
525
110.25M
122.53%
+10.44K
2025Q3
543
110.25M
126.46%
+2.35M
2025Q2
527
106.83M
124.47%
+1.78M
2025Q1
508
105.21M
122.53%
-8.81M
2024Q4
492
102.43M
107.05%
+15.47M
2024Q3
460
87.33M
121.15%
+1.87M
2024Q2
441
84.74M
119.85%
+1.98M
2024Q1
399
82.75M
110.72%
-4.21M
2023Q4
366
73.18M
119.64%
+1.80M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
12.71M
12.14%
+175.28K
+1.40%
Dec 31, 2025
Wellington Management Company, LLP
8.04M
7.68%
-344.10K
-4.11%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.94M
6.63%
+290.48K
+4.37%
Dec 31, 2025
Farallon Capital Management, L.L.C.
6.93M
6.62%
+1.16M
+20.16%
Dec 31, 2025
Driehaus Capital Management, LLC
6.39M
6.1%
-93.87K
-1.45%
Dec 31, 2025
T. Rowe Price Associates, Inc.
5.12M
4.89%
-84.32K
-1.62%
Dec 31, 2025
Janus Henderson Investors
4.44M
4.24%
+581.90K
+15.08%
Dec 31, 2025
EcoR1 Capital, LLC
4.29M
4.1%
--
--
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Pharmaceuticals ETF
3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.92%
Tema Heart & Health ETF
1.9%
ALPS Medical Breakthroughs ETF
1.79%
iShares U.S. Pharmaceuticals ETF
1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
1.31%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
ProShares Ultra Nasdaq Biotechnology
0.52%
Invesco Nasdaq Biotechnology ETF
0.4%
iShares Biotechnology ETF
0.34%
查看更多
State Street SPDR S&P Pharmaceuticals ETF
佔比3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比2.92%
Tema Heart & Health ETF
佔比1.9%
ALPS Medical Breakthroughs ETF
佔比1.79%
iShares U.S. Pharmaceuticals ETF
佔比1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
佔比1.31%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.92%
ProShares Ultra Nasdaq Biotechnology
佔比0.52%
Invesco Nasdaq Biotechnology ETF
佔比0.4%
iShares Biotechnology ETF
佔比0.34%
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有